Pete Pharma and Atrium24 Enter Strategic Partnership to Expand Access to Pharmaceutical 3D Printing for Independent Pharmacies
Pete Pharma, a pharmaceutical innovation and IP development company focused on modernizing dosage forms through advanced 3D printing and proprietary delivery systems, today announced a strategic partnership with Atrium24 Technologies, Inc., a fast-growing pharmacy technology and GPO platform serving independent pharmacies nationwide.
Pete Pharma and Curexa Enter Strategic Partnership to Accelerate Innovation in Compounded Therapies for the Telehealth Market
Pete Pharma, a leader in pharmaceutical innovation and pharmaceutical IP development, is proud to announce a strategic partnership with Curexa, a nationally recognized 503A pharmacy serving a growing network of telehealth providers. This collaboration is designed to support Curexa’s continued growth through access to Pete Pharma’s intellectual property, formulation expertise, and scalable product development infrastructure.
A Pharmacy-First Approach to Innovation: Pete Pharma and FABRX Announce Partnership
Pete Pharma announced today a groundbreaking partnership with FABRX, the global pioneer of pharmaceutical 3D printing, to introduce this innovative technology to the U.S. compounding pharmacy market.
